Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor

  1. Conny Gysemans1,
  2. Evelyne van Etten1,
  3. Lutgart Overbergh1,
  4. Annapaula Giulietti1,
  5. Guy Eelen1,
  6. Mark Waer2,
  7. Annemieke Verstuyf1,
  8. Roger Bouillon1 and
  9. Chantal Mathieu1
  1. 1Laboratory of Experimental Medicine and Endocrinology, Department of Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
  2. 2Laboratory of Experimental Transplantation, Department of Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
  1. Address correspondence and reprint requests to Chantal Mathieu, MD, PhD, LEGENDO, Campus Gasthuisberg O&N1, Katholieke Universiteit Leuven, Herestraat 49, 3000 Leuven, Belgium. E-mail: chantal.mathieu{at}med.kuleuven.be

Abstract

OBJECTIVE— Vitamin D deficiency increases risk for type 1 diabetes in genetically predisposed individuals, while high doses of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] prevent insulitis and diabetes in NOD mice.

RESEARCH DESIGN AND METHODS— Since 1,25(OH)2D3 regulates gene transcription through the vitamin D receptor (VDR), we investigated the role of VDR in diabetes development by creating NOD mice without functional VDR.

RESULTS— VDR−/− NOD mice are rachitic and have lower numbers of putative regulator cells [TCR-α/β+CD4CD8 (natural killer T-cells) and CD4+CD25+ T-cells [in central and peripheral immune organs compared with VDR+/+ NOD littermates. Lipopolysaccharide-stimulated VDR−/− NOD macrophages expressed lower interleukin (IL)-1, IL-6, and CC chemokine ligand 2 mRNA, correlating with less nuclear translocation of p65 nuclear factor-κB compared with VDR+/+ NOD macrophages. Thymic and lymph node dendritic cells from VDR−/− NOD mice displayed an even less mature CD11c+CD86+ phenotype than VDR+/+ NOD mice. Despite this immune phenotype linked to diabetes in NOD mice, VDR−/− NOD mice developed insulitis and diabetes at the same rate and incidence as VDR+/+ NOD littermates.

CONCLUSIONS— Despite aggravating known immune abnormalities in NOD mice, disruption of VDR does not alter disease presentation in NOD mice in contrast to the more aggressive diabetes presentation in vitamin D–deficient NOD mice.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 24 October 2007. DOI: 10.2337/db07-1095.

  • Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db07-1095.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted October 16, 2007.
    • Received August 6, 2007.
« Previous | Next Article »Table of Contents